{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58602-832",
      "generic_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride",
      "labeler_name": "Aurohealth LLC",
      "brand_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache",
      "active_ingredients": [
        {
          "name": "NAPROXEN SODIUM",
          "strength": "220 mg/1"
        },
        {
          "name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
          "strength": "120 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58602-832-67",
          "description": "2 BLISTER PACK in 1 CARTON (58602-832-67)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20220601",
          "sample": false
        },
        {
          "package_ndc": "58602-832-83",
          "description": "1 BLISTER PACK in 1 CARTON (58602-832-83)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
          "marketing_start_date": "20220601",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aurohealth LLC"
        ],
        "rxcui": [
          "1367426"
        ],
        "spl_set_id": [
          "10a8a74b-11d1-490e-87e7-d705fe0e7602"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "9TN87S3A3C",
          "6V9V2RYJ8N"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "0287563f-3472-401d-b95f-9694258def17",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220601",
      "product_id": "58602-832_0287563f-3472-401d-b95f-9694258def17",
      "application_number": "ANDA211360",
      "brand_name_base": "Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache",
      "pharm_class": [
        "Adrenergic alpha-Agonists [MoA]",
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "alpha-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}